Skip to content
OpenCapital
Get started

InMed Pharmaceuticals INM Q4 2024 earnings

Reported February 12, 2025 · Before market open

Revenue$772.5M
EPS-$3.64

Next report

Sep 23, 2026 (in 2 months)
EPS estimate-$94.44

Versus estimates

Revenue

Q1 2026$1.3MMiss by $658.6MQ4 2025$1.1MQ3 2025$1.1MQ2 2025$1.8MQ1 2025$1.8M
Q4 2024$772.5M

Diluted EPS

Q1 2026-$0.69Beat by $93.75Q4 2025-$0.51Q3 2025-$0.44Q2 2025-$3.80Q1 2025-$1.94
Q4 2024-$3.64

Ask the moment InMed Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did InMed Pharmaceuticals report Q4 2024 earnings?
InMed Pharmaceuticals (INM) reported Q4 2024 earnings on February 12, 2025 before market open.
What were InMed Pharmaceuticals's Q4 2024 revenue and EPS?
InMed Pharmaceuticals reported revenue of $772.5M and eps of $-3.64 for Q4 2024.
Where can I find InMed Pharmaceuticals's Q4 2024 SEC filings?
You can read the 10-Q periodic report (0001213900-25-013063) directly on SEC EDGAR. The filing index links above go to sec.gov.